CAM
RMTI icon

ClariVest Asset Management’s Rockwell Medical RMTI Stock Holding History

ClariVest Asset Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,420
Closed -$279K – 946
2023
Q3 		$279K Buy
+13,420
New +$408K 0.02% 367

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClariVest Asset Management's RMTI Position: Q4 2023 in Review

ClariVest Asset Management sold out of Rockwell Medical (RMTI) in Q4 2023, closing a stake of 13,420 shares — an estimated $279K sold.

ClariVest Asset Management first reported a position in RMTI in Q3 2023 and held it in 1 quarter. The position peaked at $279K in Q3 2023. 34 funds tracked by Wall St. Rank hold RMTI as of Q4 2023.

  • ClariVest Asset Management reported no remaining Rockwell Medical position as of Q4 2023 after selling out during the quarter.
  • ClariVest Asset Management sold 13,420 Rockwell Medical shares in Q4 2023, an estimated $279K.
  • ClariVest Asset Management first reported a position in Rockwell Medical in Q3 2023 and held it in 1 quarter.
  • ClariVest Asset Management's Rockwell Medical position peaked at $279K in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2023.

Based on ClariVest Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.